• Revenues of $5.0 billion, in line with the first quarter of 2014.
• Organic revenue growth of 8% excluding the impact of foreign exchange fluctuations and the divestment of the U.S. OTC plants.
• Non-GAAP operating income of $1.5 billion, an increase of 11% compared to the first quarter of 2014. GAAP operating income of $749 million, down 23%.
• Non-GAAP net income of $1.2 billion, up 11%. GAAP net income of $446 million, a decrease of 40%.
• Non-GAAP diluted EPS of $1.36, an increase of 11%. GAAP diluted EPS of $0.52, a decrease of 40%.
Help employers find you! Check out all the jobs and post your resume.
